Recent Price Movement and Market Context
On 27 Feb 2026, Bajaj Healthcare Ltd’s stock price touched Rs.329, its lowest level in the past 52 weeks. This decline comes after two consecutive days of losses, during which the stock has fallen by 3.93%. The day’s performance was broadly in line with the Pharmaceuticals & Biotechnology sector, which also faced pressure amid a negative market mood. The Sensex opened flat but later declined by 533.14 points, or 0.68%, closing at 81,687.34. While the S&P BSE Oil & Gas index hit a new 52-week high on the same day, Bajaj Healthcare’s shares continued to lag behind.
The stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a sustained bearish trend. This technical weakness compounds the stock’s underperformance relative to the broader market, with Bajaj Healthcare delivering a negative return of 46.50% over the last 12 months, compared to the Sensex’s positive 9.49% gain.
Fundamental Performance and Financial Metrics
Bajaj Healthcare’s long-term fundamentals have shown signs of strain, contributing to its current valuation challenges. The company’s operating profits have contracted at a compound annual growth rate (CAGR) of -9.00% over the past five years, indicating a weakening earnings base. Additionally, the firm’s debt servicing capacity remains limited, with a Debt to EBITDA ratio of 2.59 times, reflecting a relatively high leverage position that may constrain financial flexibility.
Despite these headwinds, the company has reported positive earnings growth in recent quarters. The profit after tax (PAT) for the nine months ended recently stood at Rs.42.41 crores, representing a growth rate of 22.82%. Quarterly operating profit to interest coverage reached a peak of 5.22 times, while net sales for the quarter hit Rs.161.22 crores, the highest recorded in recent periods. These figures suggest some operational resilience amid broader challenges.
Momentum just kicked in! This Small Cap from the Auto - Trucks sector entered our list with explosive short-term signals. Catch the wave while it's still building!
- - Fresh momentum detected
- - Explosive short-term signals
- - Early wave positioning
Valuation and Comparative Analysis
The company’s return on capital employed (ROCE) stands at 8.1%, which, while modest, supports an attractive valuation profile. Bajaj Healthcare’s enterprise value to capital employed ratio is 1.8, indicating that the stock is trading at a discount relative to its peers’ historical averages. The price-to-earnings-to-growth (PEG) ratio of 1.1 further suggests that the market is pricing in subdued growth expectations despite recent profit increases of 18.4% over the past year.
However, the stock’s performance relative to broader market indices and sector benchmarks remains below par. Bajaj Healthcare has underperformed the BSE500 index over the last three years, one year, and three months, underscoring persistent challenges in delivering shareholder returns. The stock’s 52-week high was Rs.744.9, highlighting the significant decline in market valuation over the past year.
Shareholding and Market Grade
The majority ownership of Bajaj Healthcare remains with promoters, maintaining a stable shareholding structure. The company’s overall market capitalisation grade is rated 4, reflecting its mid-tier size within the Pharmaceuticals & Biotechnology sector. The recent downgrade in the Mojo Grade from Sell to Strong Sell on 19 Jan 2026, with a current Mojo Score of 29.0, signals a cautious stance based on the company’s financial and market performance metrics.
Considering Bajaj Healthcare Ltd? Wait! SwitchER has found potentially better options in Pharmaceuticals & Biotechnology and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - Pharmaceuticals & Biotechnology + beyond scope
- - Top-rated alternatives ready
Sectoral and Market Influences
The Pharmaceuticals & Biotechnology sector has experienced mixed performance recently, with some indices reaching new highs while others face pressure. Bajaj Healthcare’s stock movement has been influenced by broader market trends, including the Sensex trading below its 50-day moving average, although the 50DMA remains above the 200DMA, indicating some underlying market support. The sector’s overall performance today was negative, aligning with the stock’s decline.
Summary of Key Financial Indicators
Over the last year, Bajaj Healthcare’s stock price has declined by 46.50%, contrasting with the Sensex’s 9.49% gain. The company’s operating profit CAGR over five years is negative at -9.00%, while recent quarterly results show positive trends in PAT growth and sales. The Debt to EBITDA ratio of 2.59 times points to a leveraged balance sheet, and the Mojo Grade downgrade to Strong Sell reflects these financial pressures. Despite these challenges, the company maintains a promoter majority shareholding and trades at a valuation discount compared to peers.
Conclusion
Bajaj Healthcare Ltd’s stock reaching a 52-week low of Rs.329 highlights ongoing pressures in both market sentiment and company fundamentals. The stock’s sustained trading below key moving averages and underperformance relative to benchmarks underscore the challenges faced. While recent quarterly results indicate some improvement in profitability and sales, the longer-term financial metrics and leverage ratios continue to weigh on the stock’s valuation and market perception.
Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →
